To determine whether an additional copy of chromosome 21 genes other than APP modified APP/amyloid-β biology we crossed the J20 APP transgenic (tgAPP) mouse model, which expresses human APP with AD-associated point mutations, with a panel of mouse models of DS (Fig. 1A). This evidence concerns the gene APP and Alzheimer disease.